Cofepris. Address shortage of medicines, first action of Svarch

Alejandro Svarch Pérez assumed the position of head of the Federal Commission for the Protection against Sanitary Risks (Cofepris) and announced that the first strategic line in his work plan will be to address the shortage of medicines.

During the ceremony, Jorge Alcocer, Secretary of Health, said that the appointment It is an important step in the commission’s change of course, to strengthen actions against corruption and opacity, fundamental principle of the Government of Mexico.

At the Cofepris facilities, Alcocer entrusted the new commissioner promote and protect public health with a transparent and efficient regulatory system, which helps to guarantee timely access to the market for health care products.

When presenting a diagnosis of the current situation of Cofepris, the Secretary of Health highlighted the Need to redefine the institutional role and strengthen the non-delegable functions of this body.

He considered that in this new stage the transformation process and recognized the work of José Alonso Novelo Baeza during the two years he was in charge of this institution, who leaves office for health reasons.

The new head of Cofepris, Alejandro Svarch Pérez, affirmed that his management will focus on enforcing the attributions of this agency, including the sanitary regulation of all products and services that require it, such as the analysis and certification of vaccines against covid-19 to help make the human right to health effective.

He presented his work program in which he highlighted as the first strategic line address the shortage of medicines, with the operation of integral working cells in which federal institutions will participate. Regulatory frameworks will also be updated and Processes will be simplified to reduce administrative procedures, among others.

The Undersecretary of Prevention and Health Promotion, Hugo López-Gatell, highlighted the urgency of carrying out an operational reorganization based on three axes: professionalization, transparency and fairness in the treatment of regulated subjects by the commission to shield it against any conflict of interest or act of corruption.

He affirmed that the assignment of Cofepris to the Undersecretariat of Prevention and Health Promotion opened the opportunity to accelerate the transition to the transformation agenda set by the Government of Mexico and by the Secretary of Health, Jorge Alcocer Varela, without taking away from Cofepris its technical and managerial autonomy.

He rated Alejandro Svarch as an upright and capable public servant. As an example, he said that while he served as director of International Relations of the Ministry of Health, he managed to get Mexico to enter the Revolving Fund of the Pan American Health Organization (PAHO), for the purchase of supplies and medicines, which represented facing very powerful interests from the pharmaceutical industry.

During his tenure at the head of the General Medical Coordination of the Health Institute for Well-being (Insabi), More than 50 thousand health workers were hired to face the covid-19 pandemic and the offer of medical specialties was expanded.

Alejandro Svarch Pérez specialized in Internal Medicine at UNAM, with clinical training at the Hospital Central Sur de Alta Especialidad Pemex; at the Salvador Zubirán National Institute of Medical Sciences and Nutrition; in the Regional Hospital of High Specialty of Yucatan; and at the Hadassah University Medical Center in Jerusalem. He is certified as a specialist in Internal Medicine by the National Regulatory Committee of Medical Specialties Councils, Conacem.

During 2018, He served as Director of Health Policies at the Inter-American Conference on Social Security; In 2017, he was a member of the Board of Directors of Doctors Without Borders (MSF); and Deputy Director of the Independent Laboratory for the Development of Evidence in Environmental Health.